Author Affiliations: Department of Dermatology, Hospital Cl ínic, Universitat de Barcelona, Spain.
Sarcoidosis is a multisystemic disorder characterized by noncaseating granulomas made up of macrophages and T cells. Isolated extrapulmonary disease has been reported in 10% of cases.1 We present a rare case of isolated tongue involvement that responded to cyclosporine.
A 46-year-old healthy woman presented with tender lesions in her tongue of 2 years' duration. She denied a history of smoking, trauma, amalgams, or piercings. Examination revealed several firm nodules on the dorsal aspect of her tongue (Figure 1). A punch biopsy specimen showed well-defined, noncaseating epithelioid granulomas affecting the submucosal and muscular layers (Figure 2). Foreign material was not identified. Findings of analysis with special stains and fungal and mycobacterial cultures were negative. The tuberculin skin test result was negative.
Figure 1. Several firm and nonmobile nodules on the dorsal aspect of the tongue.
Figure 2. A noncaseating epithelioid cell granuloma infiltrating the muscular layer of the tongue (hematoxylin-eosin, original magnification ×200).
The patient underwent a full sarcoidosis workup (complete blood cell count, liver and renal function test, angiotensin-converting enzyme determination, 24-hour calcium in urine test, and serologic analysis for syphilis and hepatitis C and B viruses, ophthalmologic examination, pulmonary function testing, chest high-resolution computed tomography, and abdominal ultrasonography) that revealed no abnormalities. She was diagnosed as having sarcoidal granulomas of the tongue, as a probable isolated form of sarcoidosis.
Prednisone treatment (45 mg/d) was initiated, and the nodules improved dramatically over 5 weeks. The lesions relapsed after glucocorticoid treatment was discontinued. We sequentially administered methotrexate (15 mg/wk) and etanercept (50 mg/wk) without improvement. Finally, we performed a wide excision of the lesions, but 1 year later, the lesions relapsed. We started cyclosporine treatment (3 mg/kg/d) with full and quick clinical remission. After 1 year of continuing cyclosporine treatment, the lesions have not relapsed .
Oral sarcoidosis manifestations include tongue nodules,2 split papules of the lips, diffuse gingival enlargement, and strawberry gums.3 To our knowledge, there is only 1 reported case of isolated sarcoidal involvement of the tongue presenting as multiple nodules.4 Infectious granulomas of the oral mucosa were ruled out in our case by the negative findings of analysis with cultures and stains. Furthermore, the patient's condition did not worsen but responded to glucocorticoids and cyclosporine. Other noninfectious granulomatous disorders that were considered are foreign-body granulomas and orofacial granulomatosis (OG), a clinicopathological spectrum comprising Melkenson-Rosenthal syndrome, granulomatous cheilitis, and Crohn disease. There are histologic differences that may help to differentiate OG from sarcoidosis: (1) granulomas in OG are subtle and poorly formed and close to blood vessels (especially lymphatics); and (2) edema and vascular dilatation are frequent findings in OG.5 However, since we did not performed endoscopy, and taking into account that asymptomatic cases of Crohn disease exist, we cannot fully exclude this entity in our patient.
The patient demonstrated a quick, complete, and sustained remission with cyclosporine treatment. Cyclosporine may inhibit sarcoid granulomas by suppressing surrounding T-cell activity. Sarcoid skin lesions and optic neuropathy have been reported to respond to cyclosporine.6 Patients who underwent liver transplantation for hepatic sarcoidosis and were undergoing cyclosporine therapy had no disease recurrence.7 However, in a trial on the efficacy of cyclosporine in pulmonary sarcoidosis, this agent did not show benefit.8 Nonetheless, it is possible that the efficacy of cyclosporine may be influenced by the organ involved.
In our case, a full study to detect sarcoid involvement in other organs detected no involvement. One might argue that our case does not meet the criteria of sarcoidosis. Although the clinical likelihood of sarcoidosis rises when there is more than 1 affected organ, cases of “monorganic ” sarcoidosis have been reported.1 In these cases, a sarcoidal reaction (maybe induced by the same stimulus present in conventional sarcoidosis) may take place compartmentalized to just 1 anatomic site. Alternatively, our patient might have had subclinical sarcoid involvement of other organs that we were not able to detect with the currently available tests. In any case, periodic assessment for involvement of other organs seems reasonable in cases of isolated sarcoidal granulomas.
Correspondence: Dr Guilabert, Servicio de Dermatolog ía, Hospital Cl ínic, Villarroel 170, 08036 Barcelona, Spain (tonovidal@gmail.com).
Financial Disclosure: None reported
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.